Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie — Clinical Trial Site

78 Registered trials

29 Currently recruiting

Organisation

Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie

Location

Lublin, Poland

Identifier

ORG-100043010

Address

Ul. Stanislawa Staszica 16, 20-081, Poland

Departments

Department of Hematooncology and Bone Marrow Transplantation
Hematology
Hematology and Bone Marrow Transplantation
I Klinika Ginekologii Onkologicznej i Ginekologii
II Klinika Anestezjologii i Intensywnej Terapii
II Klinika Anestezjologii i Intensywnej Terapii SPSK 1
Katedra i Klinika Dermatologii, Wenerologii i Dermatologii Dziecięcej
Katedra i Klinika Hematologii i Transplantacji Szpiku
Klinika Hematoonkologii i Transplantacj
Klinika Chirurgii Onkologicznej
Klinika Chirurgii Siatkówki i Ciała Szklistego
Klinika Dermatologii, Wenerologii i Dermatologii Dziecięcej
Klinika Dermatologii, Wenerologii I Dermatologii Dzieciecej Gabinet Badań Klinicznych
Klinika Hematologii i Transplantacji Szpiku
Klinika Hematoonkologii
Klinika Hematoonkologii i Transplantacji Szpiku
Klinika Hematoonkologii i Transplantacji Szpiku
Klinika Hematoonkologii i Transplantacji Szpiku
Klinika Hematoonkologii i Transplantacji Szpiku Oddział Hematoonkologii i Transplantacji Szpiku i Ch
Klinika Hematoonkologii i Transplantacji Szpiku UM
Klinika Hematoonkologii i Transplantacji Szpiku UM w Lublinie
Klinika Hematoonkologii, Transplantacji Szpiku i Chemioterapii
N/A
NA
Oddzial Hematoonkologii, Transplantacji Szpiku i Chemioterapii
Oddzial Onkologii i Chemioterapii Kliniki Chrurgii Onkologicznej
Oddzial Onkologii Klinicznej
Oddzial Onkologii Klinicznej i Chemioterapii
Oddział Chirurgii Siatkówki i Ciała Szklistego
Oddział Dermatologii i Wenerologii
Oddział Hematologii, Transplantacji Szpiku i Chemioterapii
Oddział Hematoonkologii Transplantacji Szpiku i Chemioterapii
Oddział Hematoonkologii, Transplantacji Szpiku i Chemioterapii
Oncology
Ophthalmology Department
Szpital Kliniczny nr 1 w Lublinie
Zakład Diagnostyki Obrazowej

Clinical trials at this site (78)

Search interface

MAGIC AML - Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy - of Acute Myeloid Leu… Recruiting

2023-503394-37-00 Acute Myeloid Leucaemia 5 2024-10-23
Clinical trial testing an investigational drug RVU120 for myelofibrosis (myeloproliferative neoplasm, MPN) Recruiting

2024-511688-27-00 Myelofibrosis 4 2024-09-19
A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in Participants… Recruiting

2022-501697-19-01 Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Ly 5 2024-06-18
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study with Open-Label Extension Evalu… Recruiting

2023-508818-42-00 Generalized Epidermolysis Bullosa Simplex (EBS) 10 2024-05-21
A study to investigate the safety and clinical activity of belantamab for the treatment of multiple myeloma when used as monotherapy and in … Recruiting

2022-501941-63-00 Multiple myeloma 7 2023-12-13
A study to assess efficacy of citicoline on visual field preservation in patients with glaucoma Recruiting

2022-502273-42-00 Glaucoma 5 2023-11-08
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination… Recruiting

2023-503442-30-00 Multiple Myeloma 5 2022-10-14
A Phase 3 Study Comparing Pirtobrutinib to Ibrutinib in CLL/SLL Recruiting

2023-507699-38-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2022-08-30
A trial to learn how well AZD0901 works and how safe it is compared to standard cancer treatments in adults with advanced and metastatic gas… Ended

2023-508276-11-00 Gastric cancer, Advanced/Metastatic Gastric cancer, Gas 5 2025-01-17
A Phase 3 study of Etentamig vs Standard Available Therapies in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) (3L+ RRMM Monot… Ended

2023-506668-15-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2024-06-17
A trial to learn if rilvegostomig with chemotherapy given after surgery is safe in people with biliary tract cancer and works to delay when … Ended

2023-506054-20-00 Adenocarcinoma of the biliary tract (intrahepatic or ex 5 2024-06-05
A Phase 3b Study of BMS-986346 in Lower-risk Myelodysplastic Syndrome Participants Ended

2023-504541-31-00 Myelodysplastic syndrome 5 2024-03-06
A Study to Learn How Linvoseltamab (REGN5458) Will Work Compared to the Elotuzumab, Pomalidimide and Dexamethasone (EPd) Combination, in Par… Ended

2022-501396-62-00 Relapsed Refractory Multiple Myeloma 5 2023-12-12
A phase 1/2 study of SLN124 in patients with Polycythemia Vera Ended

2023-503544-13-00 Polycythemia Vera 9 2023-11-02
A Phase 2a, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of sapablurs… Ended

2024-512482-14-00 Polycythemia Vera 4 2023-06-21
A Phase 3 Randomized Study Comparing Teclistamab Monotherapy versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethas… Ended

2023-503444-13-00 Relapsed/refractory multiple myeloma 5 2023-03-29
SC versus IV isatuximab in combination with pomalidomide and dexamethasone in RRMM Ended

2023-508869-32-00 Cancer - Plasma cell myeloma recurrent 5 2022-11-10
A Phase 3 study of Tafasitamab plus Lenalidomide in patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Ended

2023-505579-53-00 Diffuse large B-cell lymphoma (DLBCL) 5 2022-10-25
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-… Ended

2023-506871-88-00 Relapsed/Refractory Multiple Myeloma 3 2022-10-07
Ivabradine for PREVENTion of Myocardial Injury after Noncardiac Surgery (MINS) - PREVENT-MINS Trial Ended

2024-515226-81-00 Myocardial Injury after Noncardiac Surgery 5 2022-06-02
A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Profiles of CGT9486 in subjects with Advanced Systemic Mastocy… Ended

2024-511407-42-00 Advanced Systemic Mastocytosis 4 2022-01-10
A Phase 3 Study Comparing Pirtobrutinib (LOXO-305) to Bendamustine plus Rituximab in Untreated Patients with CLL/SLL Ended

2024-511599-33-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2021-12-22
A Phase 3 Trial of Fixed Duration Pirtobrutinib (LOXO-305) plus Venetoclax and Rituximab versus Venetoclax and Rituximab in Previously Treat… Ended

2023-507698-16-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2021-10-14
A Phase 3 study of Tafasitamab plus Lenalidomide in addition to Rituximab, versus Lenalidomide plus Rituximab in patients With Relapsed/Refr… Ended

2023-504684-16-00 follicular lymphoma (FL) and marginal zone lymphoma (MZ 5 2021-06-05